Bristol-Myers Squibb
PulseAugur coverage of Bristol-Myers Squibb — every cluster mentioning Bristol-Myers Squibb across labs, papers, and developer communities, ranked by signal.
No coverage in the last 90 days.
2 day(s) with sentiment data
-
Pharma leaders seek stable FDA amid pricing policy concerns
Pharmaceutical industry leaders are advocating for stability and predictability from the next Food and Drug Administration (FDA) commissioner following a period of leadership changes and uncertainty. CEOs from major dru…
-
Hengrui inks $15.2B global drug development deal with BMS
Chinese pharmaceutical company Hengrui has entered into a global collaboration and licensing agreement with US giant Bristol Myers Squibb (BMS). The deal, valued at up to US$15.2 billion, involves the development of 13 …
-
Innovent Biologics and Bristol Myers Squibb partner on 13 early-stage drug projects
Innovent Biologics has entered into a global strategic collaboration and licensing agreement with Bristol Myers Squibb to advance 13 early-stage projects across oncology, hematology, and immunology. This partnership aim…
-
Bristol Myers Squibb leads drug industry in AI adoption for manufacturing
Bristol Myers Squibb is an outlier among American manufacturers for its early adoption of artificial intelligence in its factories. While many companies are hesitant to integrate AI, this drugmaker is already leveraging…